Immatics NV (IMTX)
10.94
+0.13
(+1.20%)
USD |
NASDAQ |
May 17, 16:00
10.94
0.00 (0.00%)
After-Hours: 20:00
Immatics Free Cash Flow (Quarterly): -45.38M for March 31, 2024
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | -45.38M |
December 31, 2023 | 76.06M |
September 30, 2023 | -40.24M |
June 30, 2023 | -19.48M |
March 31, 2023 | -30.12M |
December 31, 2022 | -29.87M |
September 30, 2022 | -34.91M |
June 30, 2022 | 44.62M |
March 31, 2022 | 119.20M |
Date | Value |
---|---|
December 31, 2021 | -32.39M |
September 30, 2021 | -27.69M |
June 30, 2021 | -26.13M |
March 31, 2021 | -20.76M |
December 31, 2020 | -23.79M |
September 30, 2020 | -41.40M |
June 30, 2020 | -20.29M |
March 31, 2020 | -15.27M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-45.38M
Minimum
Mar 2024
119.20M
Maximum
Mar 2022
-9.872M
Average
-26.13M
Median
Jun 2021
Free Cash Flow (Quarterly) Benchmarks
MorphoSys AG | -- |
Affimed NV | -27.55M |
InflaRx NV | -16.17M |
BioNTech SE | -493.35M |
CureVac NV | -61.17M |